GFM
GMAB icon

GF Fund Management’s Genmab GMAB Stock Holding History

GF Fund Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.5K Buy
1,364
+51
+4% +$1.35K ﹤0.01% 425
2026
Q1 		$35.2K Buy
1,313
+165
+14% +$4.95K ﹤0.01% 440
2025
Q4 		$35.4K Buy
1,148
+248
+28% +$7.73K ﹤0.01% 444
2025
Q3 		$27.6K Sell
900
-173
-16% -$4.22K ﹤0.01% 452
2025
Q2 		$22.2K Hold
1,073
– – ﹤0.01% 491
2025
Q1 		$21K Buy
1,073
+193
+22% +$4.05K ﹤0.01% 497
2024
Q4 		$18.4K Buy
+880
New +$19.3K ﹤0.01% 479

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

GF Fund Management's GMAB Position: Q2 2026 in Review

GF Fund Management increased its Genmab (GMAB) stake by 3.9% in Q2 2026, buying an estimated $1.35K and bringing the position to 1,364 shares worth $37.5K. The position accounts for ﹤0.01% of the portfolio, ranked #425.

GF Fund Management first reported a position in GMAB in Q4 2024 and has held it in 7 quarters since. 292 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • GF Fund Management held 1,364 shares of Genmab worth $37.5K as of Q2 2026.
  • GF Fund Management bought 51 Genmab shares in Q2 2026, an estimated $1.35K.
  • Genmab made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #425 holding.
  • GF Fund Management first reported a position in Genmab in Q4 2024 and has held it in 7 quarters since.
  • 292 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.